BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20162280)

  • 1. Retroperitoneal soft tissue sarcomas: experience at a single institution in Mexico.
    García-Aceituno L; Villarreal-Garza C; Perfecto M; León-Rodríguez E
    World J Surg; 2010 Jul; 34(7):1511-6. PubMed ID: 20162280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
    Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
    J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
    Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
    J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncovascular compartmental resection for retroperitoneal soft tissue sarcoma with vascular involvement.
    Bertrand MM; Carrère S; Delmond L; Mehta S; Rouanet P; Canaud L; Alric P; Quénet F
    J Vasc Surg; 2016 Oct; 64(4):1033-41. PubMed ID: 27374069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
    Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
    Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
    Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
    Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma.
    Hager S; Makowiec F; Henne K; Hopt UT; Wittel UA
    Radiat Oncol; 2017 Jan; 12(1):29. PubMed ID: 28126006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
    Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
    Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive surgical treatment of retroperitoneal sarcoma: long-term experience of a single institution.
    Erzen D; Novak J; Spiler M; Sencar M
    Surg Technol Int; 2007; 16():97-106. PubMed ID: 17429776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
    Erzen D; Sencar M; Novak J
    J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.
    Abdelfatah E; Guzzetta AA; Nagarajan N; Wolfgang CL; Pawlik TM; Choti MA; Schulick R; Montgomery EA; Meyer C; Thornton K; Herman J; Terezakis S; Frassica D; Ahuja N
    J Surg Oncol; 2016 Jul; 114(1):56-64. PubMed ID: 27076350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.
    Lewis JJ; Leung D; Woodruff JM; Brennan MF
    Ann Surg; 1998 Sep; 228(3):355-65. PubMed ID: 9742918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgery and postoperative radiation therapy in primary retroperitoneal sarcomas: experience of the cancer centre Alexis-Vautrin].
    Fuks D; Verhaeghe JL; Marchal F; Guillemin F; Beckendorf V; Peiffert D; Leroux A; Rios M; Troufléau P; Marchal C
    Cancer Radiother; 2012 May; 16(3):194-200. PubMed ID: 22387193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
    Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB
    Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroperitoneal soft tissue sarcoma: prognostic factors and therapeutic approaches.
    Pacelli F; Tortorelli AP; Rosa F; Papa V; Bossola M; Sanchez AM; Ferro A; Menghi R; Covino M; Doglietto GB
    Tumori; 2008; 94(4):497-504. PubMed ID: 18822685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
    Nathan H; Raut CP; Thornton K; Herman JM; Ahuja N; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 Dec; 250(6):970-6. PubMed ID: 19644351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
    Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
    Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
    Tattersall HL; Hodson J; Cardona K; Lee RM; Nessim C; Gladdy R; Van Der Hage J; Schrage Y; Tseng WW; van Houdt W; Novak M; Grignani G; Tolomeo F; Goel N; Ryon E; Gyorki D; Bagaria SP; Gonzalez JA; Arnau ABM; Sayyed R; Tirotta F; Evenden C; Desai A; Almond M; Glasbey J; Fiore M; Gronchi A; Ford SJ
    J Surg Oncol; 2021 Mar; 123(4):1057-1066. PubMed ID: 33368277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.
    Ng DWJ; Tan GHC; Chia CS; Chee SK; Quek R; Farid M; Teo MCC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e458-e465. PubMed ID: 28371454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.